The gut microbiome undergoes changes with age that can lead to chronic inflammation and decreased production of beneficial metabolites. Recent research shows that Alzheimer’s patients have an imbalanced gut microbiome, raising questions about its role in the disease. Understanding the mechanisms behind this correlation is crucial, and exploring new approaches, such as fecal transplants, may shed light on the potential impact of gut microbes on Alzheimer’s development. Symposiums and research efforts are delving into the microbial links to Alzheimer’s, including investigations into possible causative microbes and the effects of infections like COVID-19 on disease progression. Further research is needed to determine how specific microbes may influence Alzheimer’s and what interventions could help mitigate its effects.